Does Dr. ABDULLAH ABU KAR have financial conflicts of interest?

Dr. ABDULLAH ABU KAR (MD) has received a total of $1,083 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,083 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ABDULLAH ABU KAR?

According to CMS Open Payments data, Dr. ABDULLAH ABU KAR received funding from KESTRA MEDICAL TECHNOLOGY SERVICES ($332), ASTRAZENECA PHARMACEUTICALS ($128), and JANSSEN BIOTECH ($125).

Does Dr. ABDULLAH ABU KAR receive research grants or speaking fees?

Dr. ABDULLAH ABU KAR has received $1,083 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ABDULLAH ABU KAR

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: PHOENIX, AZ 85013

NPI Number: 1407239718

LIFETIME INDUSTRY VALUE

$1,083

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABU KAR is a verified Internal Medicine practitioner based in PHOENIX, AZ.

Between 2021 and 2024, Dr. ABU KAR had an overall industry promotional and research financial footprint of $1,083 as recorded in the federal CMS Open Payments database.

$1,083 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABU KAR's primary funding source is KESTRA MEDICAL TECHNOLOGY SERVICES, which accounts for $332 (representing 30.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

KESTRA MEDICAL TECHNOLOGY SERVICES

Rank 1

$332

30.7%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$128

11.8%

JANSSEN BIOTECH

Rank 3

$125

11.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.